Please see the attached communication from Pfizer dated 20 November 2019 entitled recommendations to avoid potentially fatal dosing errors when using methotrexate for inflammatory diseases.
Recommendations to avoid potentially fatal dosing errors when using methotrexate for inflammatory diseases
(Recommendations_to_avoid_potentially_fatal_dosing_errors_when_using_methotrexate_for_inflammatory_diseases.pdf | 927 KB)
Visit our Clinical Hub ยป
